scispace - formally typeset
W

Werner Moshage

Researcher at University of Erlangen-Nuremberg

Publications -  117
Citations -  5477

Werner Moshage is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Coronary arteries & Electron beam tomography. The author has an hindex of 30, co-authored 114 publications receiving 5369 citations.

Papers
More filters
Journal ArticleDOI

Detection of Coronary Artery Stenoses by Contrast-Enhanced, Retrospectively Electrocardiographically-Gated, Multislice Spiral Computed Tomography

TL;DR: MSCT with retrospective ECG gating permits the detection of coronary artery stenoses with high accuracy if image quality is sufficient, but its clinical use may presently be limited due to degraded image quality in a substantial number of cases.
Journal ArticleDOI

Noninvasive coronary angiography by retrospectively ECG-gated multislice spiral CT.

TL;DR: This investigation investigated the applicability and image quality of contrast-enhanced coronary artery visualization by multislice spiral CT using retrospective ECG gating to determine the visualized length of the coronary arteries, the contrast-to-noise ratio, and the correlation of...
Journal ArticleDOI

Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors.

TL;DR: A strong influence of LDL cholesterol level on the progression of AVC and CC is observed, suggesting that lipid-lowering therapy may decrease the progressionof aortic valve calcification.
Journal ArticleDOI

Value of Electron-Beam Computed Tomography for the Noninvasive Detection of High-Grade Coronary-Artery Stenoses and Occlusions

TL;DR: When image quality is adequate, electron-beam CT may be useful to detect or rule out high-grade coronary-artery stenoses and occlusions.
Journal ArticleDOI

Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.

TL;DR: Upstream administration of abciximab is not associated with a reduction in infarct size in patients presenting with acute myocardial infarction within 24 hours of symptom onset and receiving 600 mg clopidogrel.